Articles mentioning both Bayer and Investors -BoardProspects

Articles mentioning both Bayer and Investors

1-7 of 7
1. GlaxoSmithKline Gains Key Supporters in Potential Proxy Battle
  
  Explore Yahoo! Finance May 21 2021 BoardNews
  
  ...n a $40 billion takeover. It also wanted Bayer AG (XTER:BAYN) to divide its crop science and pharma business. Bayer rejected that request, but did take steps to cut costs by nearly $2 billion by 2024. Others who made maj...
  Read Full Article
  
  Comment
  
  Mentions: Management Proxy Fight acquisition
2. Activist Investor Blasts Alexion's $1.4B Portola Buy in Scathing Open Letter
  
  Explore Pharma News May 12 2020 BoardNews
  
  ...tola and its laggard bleeding drug Andexxa, which has delivered disappointing sales since its launch in 2018. Investors' negative reaction to the Portola buy––which saw Alexion lose $1.7 billion in market cap within 24 h...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Management CFO
3. Elliott Outspends Rivals as Corporate Activism Turns to Germany
  
  Explore SHARENET Jul 10 2019 BoardNews
  
  ...n had 30 with that focus at the end of the first quarter. Elsewhere in Europe, the top 10 U.S.-based activist investors have also stepped up activities. Nelson Peltz's Trian Fund Management disclosed a position in Britis...
  Read Full Article
  
  Comment
  
  Mentions: Management Hedge Fund Trian Fund
4. Bayer Board Plans to Meet After Investors Rebuke CEO
  
  Explore Bloomberg Apr 29 2019 BoardNews
  
  After 55 percent of shareholders registered their disapproval of management at the company's annual general meeting Friday, the supervisory board...
  Read Full Article
  
  Comment
  
  Mentions: Management Bayer CEO
5. Investor Revolt at Bayer to Escalate After CEO Keeps His Job
  
  Explore BNN Bloomberg Apr 27 2019 BoardNews
  
  ...areholders want Bayer to "bring out the company’s strengths to a greater extent in the future." Several large investors said they would prefer Baumann to remain in place because a change to Bayer’s management board could...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Management Takeover
6. Activist Investor Elliott Has Taken Position in Germany's Bayer
  
  Explore SHARENET Dec 7 2018 BoardNews
  
  ... mainly due to risks relating to the more than 9,000 lawsuits brought over Roundup. Investors have also urged Bayer to strengthen its drug development pipeline, even though its financial firepower was depleted by the Mon...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Procter & Gamble stake
7. Here's the presentation David Einhorn just gave to a room of elite hedge fund managers
  
  Explore Business Insider Dec 8 2016 BoardKnowledge
  
  ...ndation of the same name, check that out here). In it, he explained his long thesis for pharmaceutical giant, Bayer. Last year Bayer spun off its chemicals company, Covestro, and then in September announced a deal to tak...
  Read Full Article
  
  Comment
  
  Mentions: Conference Investor Relations Hedge Fund
8. 1-7 of 7